Please login to the form below
Blue Mesa Health
This page shows the latest Blue Mesa Health news and features for those working in and with pharma, biotech and healthcare.
Merck KGaA inks deal for Medisafe adherence app
with Blue Mesa Health to provide remote health coaching, peer support and connected technology for chronic disease patients. ... And it’s no stranger to Medisafe’s technology, having invested in the company via its mobile health investment arm
Latest news
-
Merck to pilot digital behavioural change programme
The German pharmaceutical company will work with Blue Mesa Health to provide the US digital therapeutics firm’s chronic disease prevention programme to diabetes patients. ... However, Blue Mesa Health and Merck declined to provide any details on which
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Consultant
-
competitive salary
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Vice President
-
Competitive Salary Offered
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
- Account Director or Senior Account Director
-
Salary TBC
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
Subscribe to our email news alerts
- Novartis links up with NHS for speedy access to cholesterol drug inclisiran
- NantKwest rockets on promising pancreatic cancer data
- Latecomer Lilly preps its IL-23 drug for Crohn’s disease
- Bayer bulks up in women’s health again with non-hormonal contraceptive deal
- Key success factor (KSF)
- Genital herpes vaccine candidate heads for human studies
- How do companies prepare for reimbursement?
- Lucid Group adds more magic to the mix with four new hires
- Communiqué Awards 2020 is now open for entry
- Novo Nordisk gets MACE prevention claim for Ozempic in US
- NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi
- FDA committee rejects Intellipharmaceutics’ opioid drug Aximris
PMHub
SEVEN STONES
Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....
Latest intelligence
- How do companies prepare for reimbursement?
- Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
- Integrating electronic health records into clinical trials
- How organisations are working to realise the research potential of EHRs...
- Keeping up the fight against HIV and using the lessons to tackle other threats
- Danny Buckland interviews Gilead’s Mike Elliott...
Quick links
Infographics
